Hyperpolarizer for 13C MR Metabolic Imaging of Human Subjects and Animal Models

用于人类受试者和动物模型 13C MR 代谢成像的超极化器

基本信息

  • 批准号:
    8333704
  • 负责人:
  • 金额:
    $ 200万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal is in response to the NCRR "High End Instrumentation Grant Program S10" (RFA: PAR-11- 228) to expand our investment in improved instrumentation for the advancement of biomedical research in Stanford's interdisciplinary programs including the Richard M. Lucas Center for Imaging (Lucas Center), Center for Biomedical Imaging at Stanford (CBIS), and the Molecular Imaging Program at Stanford (MIPS). Translational biomedical research is of the utmost importance today and, with the rapid advances in molecular medicine and stem cells, imaging plays a vital role. We are requesting funds to purchase a General Electric Healthcare Spinlab" dynamic nuclear polarizer needed to extend our current 13C magnetic resonance spectroscopic imaging (MRSI) efforts. Specifically, we have built a highly successful experimental hyperpolarized 13C metabolic imaging program, but, so far, only technical research and small animal studies have been conducted due to the limitations of our pre-clinical polarizer. The proposed new polarizer will allow us to build upon this program with the additional capability of performing large animal and human studies, a critical step forward in the development of this promising technology. Providing more than a 10,000 fold increase in signal-to-noise ratio (SNR) as compared to thermally polarized 13C nuclei, hyperpolarized MRS forms an important bridge between MRI and molecular imaging, and the new polarizer will enable sophisticated metabolic imaging studies of cancer, heart disease, and other pathologies while ensuring the continued development of advanced hyperpolarized 13C MRS methods for years to come. The Spinlab polarizer will be located within the Lucas Center, which operates as a university Service Center and as an NCRR-funded National Research Resource (Center for Advanced MR Technology at Stanford), supplying state-of-the-art MR instrumentation and services to the campus and broader research community. A primary mission of the Stanford Department of Radiology is the translation of promising new imaging modalities from the laboratory setting to the clinic. The acquisition of this new DNP polarizer is directly aligned with this goal and has great potential to provide new insights into health and disease, ultimately improving patient care.
描述(由申请人提供):该提案是对NCRR“高端仪器赠款计划S10”(RFA:PAR-11-228)的响应斯坦福(MIPS)。翻译生物医学研究至今至关重要,并且随着分子医学和干细胞的快速发展,成像起着至关重要的作用。我们要求资金购买一家通用的电力医疗旋转灯光“动态核偏光剂,以扩展我们当前的13C磁共振光谱成像(MRSI)的努力。具体来说,我们已经建立了一项非常成功的实验性超极化13C代谢成像程序,但到目前为止,仅允许我们的隔离度构建的层面化学技术,这使得启用了这些隔离度的启示。 additional capability of performing large animal and human studies, a critical step forward in the development of this promising technology. Providing more than a 10,000 fold increase in signal-to-noise ratio (SNR) as compared to thermally polarized 13C nuclei, hyperpolarized MRS forms an important bridge between MRI and molecular imaging, and the new polarizer will enable sophisticated metabolic imaging studies of cancer, heart disease, and other pathologies while ensuring the continued development of advanced超极化13C MRS方法已有几年。 SpinLab偏光层将位于卢卡斯中心,该中心是大学服务中心,并作为NCRR资助的国家研究资源(斯坦福大学高级MR技术中心),为校园和更广泛的研究社区提供最先进的MR仪器和服务。斯坦福大学放射学系的主要任务是将有希望的新成像方式从实验室环境转变为诊所。收购 新的DNP偏光层直接与这个目标保持一致,并具有对健康和疾病的新见解,最终改善了患者护理。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PKM2 activation sensitizes cancer cells to growth inhibition by 2-deoxy-D-glucose.
  • DOI:
    10.18632/oncotarget.19630
  • 发表时间:
    2017-10-31
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tee SS;Park JM;Hurd RE;Brimacombe KR;Boxer MB;Massoud TF;Rutt BK;Spielman DM
  • 通讯作者:
    Spielman DM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel M Spielman其他文献

Daniel M Spielman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel M Spielman', 18)}}的其他基金

Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors
脑肿瘤代谢重编程的增强氘代谢成像 (DMI)
  • 批准号:
    10593853
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
Robust 1H MRSI of GABA, Glutamate, Glutamine, and Glutathione
GABA、谷氨酸、谷氨酰胺和谷胱甘肽的稳定 1H MRSI
  • 批准号:
    9910230
  • 财政年份:
    2017
  • 资助金额:
    $ 200万
  • 项目类别:
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate
使用超极化 13C-丙酮酸 MRS 成像脑代谢
  • 批准号:
    9269573
  • 财政年份:
    2015
  • 资助金额:
    $ 200万
  • 项目类别:
Novel MRS methods for measuring brain energetics and neurotransmitter cycling
用于测量大脑能量学和神经递质循环的新 MRS 方法
  • 批准号:
    8990476
  • 财政年份:
    2015
  • 资助金额:
    $ 200万
  • 项目类别:
MEASUREMENT OF ETHANOL METABOLISM IN RAT LIVER USING MRS OF [1-13C]PYRUVATE
使用 [1-13C]丙酮酸 MRS 测量大鼠肝脏中的乙醇代谢
  • 批准号:
    8169890
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators
酒精和 ALDH2 激活剂的心脏保护作用的代谢成像
  • 批准号:
    8401178
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators
酒精和 ALDH2 激活剂的心脏保护作用的代谢成像
  • 批准号:
    8206864
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators
酒精和 ALDH2 激活剂的心脏保护作用的代谢成像
  • 批准号:
    7765749
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators
酒精和 ALDH2 激活剂的心脏保护作用的代谢成像
  • 批准号:
    8009887
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
MEASUREMENT OF ETHANOL METABOLISM IN RAT LIVER USING MRS OF [1-13C]PYRUVATE
使用 [1-13C]丙酮酸 MRS 测量大鼠肝脏中的乙醇代谢
  • 批准号:
    7955416
  • 财政年份:
    2009
  • 资助金额:
    $ 200万
  • 项目类别:

相似国自然基金

CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
  • 批准号:
    32100463
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
  • 批准号:
    21922410
  • 批准年份:
    2019
  • 资助金额:
    120 万元
  • 项目类别:
    优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
  • 批准号:
    81402157
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
  • 批准号:
    10673513
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
  • 批准号:
    10667881
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
Early life stress impacts molecular and network properties that bias the recruitment of pro-stress BLA circuits
早期生活压力会影响分子和网络特性,从而影响促压力 BLA 回路的募集
  • 批准号:
    10820820
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
Microneedle patch for the stabilization and dose-sparing delivery of rabies vaccine
用于稳定和节省剂量输送狂犬病疫苗的微针贴片
  • 批准号:
    10759732
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了